Funding will enable further development of Hicks’ minibinder conjugates as an improved option for radiotherapy cancer treatments SEATTLE, Nov. 14, 2024 /PRNewswire-PRWeb/ — Washington Research Foundation (WRF) has awarded a $387,050 phase 3 technology commercialization grant to a team…
Washington Research Foundation awards $387K grant to Derrick Hicks of the University of Washington’s Institute for Protein Design
This post was originally published on this site